Broad Experiences at an NCI Comprehensive Cancer Center
The ASHP-accredited PGY2 residency in oncology at Barnes-Jewish Hospital is designed to provide a diverse hematology and oncology experience while focusing on the needs of the individual resident. The program provides a broad experience in the numerous aspects of oncology. Completion of a residency project is required. This PGY2 residency participates in the ASHP residency match program.
Barnes-Jewish Hospital and Washington University School of Medicine are part of the Alvin J. Siteman Cancer Center. Siteman Cancer Center (SCC) is a leader in cancer treatment, research, prevention, education and community outreach. It is the only cancer center in Missouri designated as a Comprehensive Cancer Center from the National Cancer Institute and is a member of the National Comprehensive Cancer Network. Offering more than 250 clinical trials, the SCC treats more than 8,000 new patients each year and provides follow-up care for more than 25,000 cancer survivors. Additionally, Siteman Cancer Center is one of the largest bone marrow and stem cell transplant centers in the world, averaging about 400 transplants each year and more than 5,000 transplants since the program began in 1982.
Oncology pharmacy services are provided by multiple clinical oncology pharmacy specialists in both the inpatient and outpatient settings. These services include participation in daily multidisciplinary rounds, patient education, staff education and chemotherapy order entry and evaluation. Clinical pharmacy specialists assist in maintaining the continuity of care between the outpatient and inpatient setting.
Number of Positions
Two per year
BJH PGY2 Oncology Pharmacy Residency Program Structure
BJH PGY2 Oncology Pharmacy Residency Successful Completion Checklist
Katie L. Lentz, PharmD, BCOP
Program Director, PGY2 Oncology Pharmacy Residency
Department of Pharmacy
One Barnes-Jewish Hospital Plaza
St. Louis, MO 63110-1026
E-mail: [email protected]